The prospect of neurosurgical devices is broad, and the subdivision of medical devices is worthy of attention

With the development of the economy, the increase of the population, the improvement of the aging society, and the continuous enhancement of people's awareness of health care, the demand for the global neurosurgical device market continues to grow rapidly, and the medical device industry is one of the fastest growing industries in the world today. In 2017, the global medical device market size is predicted to be 403 billion US dollars. By 2022, the global medical device market size will reach 522 billion US dollars, with a CAGR annualized growth rate of 5.1% from 2016 to 2022.

Compared with the drug market, the global prescription drug market was worth US$777 billion in 2017. By 2022, it will reach US$1.043 trillion, with a CAGR annualized growth of 5.2%. In 2022, the device market will account for about half of the global drug market, and the growth rates of the two markets will be moderate.

In terms of market size, the top rankings are as follows:

In Vitro Diagnostics InVitroDiagnostics

In 2016, the market size was 49.4 billion US dollars, and the CAGR was 5.9% from 2016 to 2022, with the largest scale and the second fastest growth rate.

Cardiology

In 2016, the market scale was 44.6 billion US dollars, and the CAGR from 2016 to 2022 was 5.7%, ranking second in scale and third in growth rate.

Diagnostic Imaging

In 2016, the market scale was 39.2 billion US dollars, and the CAGR from 2016 to 2022 was 3.4%, the third in scale and the tenth in growth rate.

OrthopedicsOrthopedics

In 2016, the market scale was 35 billion US dollars, and the CAGR from 2016 to 2022 was 4.0%, the fourth in scale and the ninth in growth rate.

OphthalmologyOphthalmics

In 2016, the market size was 26 billion US dollars, and the CAGR from 2016 to 2022 was 5.3%, the fifth in scale and the fifth in growth rate.

General&plasticsurgery

In 2016, the market scale was 20.4 billion US dollars, and the CAGR from 2016 to 2022 was 5.3%, ranking sixth in scale and fifth in growth rate.

Endoscopy

In 2016, the market scale was 17.8 billion US dollars, and the CAGR was 6.4% from 2016 to 2022, the seventh in scale and the first in growth rate.

Drug Delivery DrugDelivery

In 2016, the market scale was 18.6 billion US dollars, and the CAGR was 4.8% from 2016 to 2022, the eighth in scale and the seventh in growth rate.

Wound Management Wound Management

In 2016, the market size was 13 billion US dollars, and the CAGR was 4.5% from 2016 to 2022, the ninth in scale and the eighth in growth rate.

Dental Dental

In 2016, the market size was 12.8 billion US dollars, and the CAGR was 5.6% from 2016 to 2022, the tenth in scale and the fourth in growth rate.

Diabetes

In 2016, the market scale was 11 billion, and the CAGR from 2016 to 2022 was 6.6%.

Nephrology

In 2016, the market scale was 11 billion, and the CAGR from 2016 to 2022 was 4.6%.

Hospital Equipment & SupplyGeneralHospital&HealthcareSupply

In 2016, the market scale was 11 billion, and the CAGR from 2016 to 2022 was 2.5%.

Ear, Nose & Throat (ENT)

In 2016, the market scale was 8 billion, and the CAGR from 2016 to 2022 was 5.5%.

Neurology

In 2016, the market scale was 7.4 billion, and the CAGR from 2016 to 2022 was 7.8%.

Specific to the category of neurosurgical instruments, refer to the following rankings, we can find that this segment ranks 15th. At present, the global neurosurgery planning and navigation market is huge, with a potential global market size of 1.5 billion US dollars. It is estimated that by 2020, the compound annual growth rate of the global surgical navigation system market will reach 4.5%. In China, the neurosurgery navigation market has great potential. In 2012, there were about 175 navigation systems on the market. According to the prediction of NDI Corporation in Canada, the market capacity of neuronavigation systems in my country will reach about 500 units.

Market overview of neurosurgery products at home and abroad

In this market, brain surgery planning and navigation products are currently in great demand. Looking at the US and global markets, there are 1,358 hospitals in the US with neurosurgery departments (treating inpatients with >332 questionable cases). In terms of potential SRP (planning software) installations, there are 3,500 surgical navigation systems for neurosurgery; in terms of potential SNAP (navigation software) installations, the main players in the market today are Stryker, Brainlab, Medtronic, General Motors, Siemens. By 2020, the compound annual growth rate of the global surgical navigation system market is expected to reach 4.5%.

The annual potential market plan in the United States is shown in the figure:

Note:

1 US 2012 new ranking

2 Calculated based on information from the "Medtronic 2014 Funders Meeting"

3 Shopping mall transparent investigation operation navigation shopping mall

Take the three-dimensional brain navigation project of Surgical Theater in the United States as an example: this company named Surgical Theater was established in June 2010 and is headquartered in Cleveland, Ohio. Obtained FDA certification in June and June 2014. Surgical Theater of the United States has completed the integration of its navigation platform SNAP and Medtronic's StealthStation navigation system, and the integrated system has been exhibited in several American and world-class brain surgery conferences. At present, the number of operations performed using the SNAP system has exceeded 1,000, and this number will continue to increase in the future. In 2015, the company has received a US$5 million investment from HTC. In the future, the two parties will focus on the development of VR virtual reality glasses for medical use, helping doctors to "roam" in the brain of patients before, during and after surgery, making great progress Surgical accuracy and minimal invasiveness, reducing recovery time and postoperative complications. In the fourth quarter of 2015, the company added the VR part to the SNAP system.

Its technology competition advantage is outstanding. Compared with the biggest competitors in the current navigation market and the Medtronic and Brainlab systems, the picture interface has clearer, more realistic, more perfect 3D effects, and features and functions such as tactile feedback, and can be compared with the current The mainstream navigation equipment is fully integrated. Moreover, the company's products are mature, and have passed FDA, CE certification and completed sales. Mayo Clinic, Mount Sinai, UCLA and other famous American hospitals have already adopted its equipment, which reflects the advanced nature of its technology from the side.

On the other hand, the company's management team has rich experience and a stable structure, including former Israeli Air Force R&D officials and engineers, as well as neurosurgery directors from Mayo Clinic, Mount Sinai, UCLA and other top American hospitals as the center's opinion leader, which can be useful Promote the combination of forward-looking and practical skills in the company.

On December 18, 2015, at the annual meeting of HTC Corporation in Taiwan, ST's three-dimensional navigation technology was successfully displayed. As the main core investment project of HTC's future important strategic direction VR, it was personally recommended by Ms. Wang Xuehong!

American Surgical Theater Company now has two major product lines. The SRP-neurosurgery preoperative planning system can use the patient's existing CT or MRI image materials for image fusion processing and three-dimensional reconstruction to generate a realistic 3D brain stereoscopic image to assist doctors in investigating the relationship between the lesion and the surrounding tissue on the virtual image Spatial relationship, select the best surgical tools, plan the optimal surgical approach and perform surgical simulation, thereby improving surgical safety. The SNAP-neurosurgery navigation system can be integrated with mainstream intraoperative navigation equipment, combined with the 3D images generated in the planning system before, to help doctors accurately locate and identify lesion tissues, highlight important blood vessels, nerves and other functional tissues, and reduce the surrounding Damage to the tissue improves the resection rate of the lesion and the accuracy of surgery, and reduces the risk of surgery. For example, the new generation of EndoSNAP products will enable doctors to not only see the endoscope's field of view when performing surgery with an endoscope, but also see the endoscopic field of view in the 3D model of the patient's brain in real time. Helping physicians see the pathological tissue around the endoscope, this technology has been verified at UCLA and has received good responses.

Ultimately, why was such a project so badly needed in the marketplace at the time?

The current surgical preparation is limited to observing pictures, but with the increase in the use of instruments, minimally invasive treatments, and robotics, surgical operations have become more and more complicated, and detailed planning of operations has become an urgent need. The current level of surgical preparation is limited to "brain" planning; the performance of surgeons and hospitals is constrained by personal experience. For this reason, American Surgical Theater Company specializes in providing realistic 3D surgical planning and guidance for patients, which has been certified by the FDA. In short, the market needs a good navigation system to improve the success rate of surgery.

In addition, in the Chinese market, the Neurosurgery Department of Huashan Hospital affiliated to Fudan University introduced the first Medtronic StealthStation neuronavigation system in September 1997, opening the door to the neuronavigation system market in my country. Although the domestic neuronavigation market started late, the market potential is huge. With the improvement of the economic foundation and technical strength of major hospitals, by the end of 2012, there are now 191 navigation systems, mainly concentrated in Beijing, Shanghai, Guangzhou and coastal developed areas. According to the prediction of Canadian NDI Company, the market capacity of domestic neuronavigation system will reach about 500 units.

At present, the domestic navigation market is dominated by imported equipment. The sales of Medtronic and Brainlab systems in my country are 89 and 53 respectively, with market shares of 46.6% and 27.7%. Domestic equipment such as Fudan’s Excelim-04 system With a sales volume of 30 units and a market share of 15.7%, it can be said that the development of domestic navigation systems still has a long way to go.

At present, Surgical Theater in the United States has received tens of millions of dollars in investment from HTC and Shanghai Chuangrui.